Pharmaceutical

STAT+: Taysha Gene Therapies’ plan to tackle rare disea...

The shrinking of Taysha Gene Therapies has left many families, who funded the ea...

STAT+: Mass General Brigham CEO opens up about the Dana...

The CEO of Mass General Brigham discussed the system’s split with Dana-Farber Ca...

AI is a pillar of tomorrow’s healthcare system, but lim...

At the industry crossroads of healthcare and pharmaceuticals at the Life Science...

Amicus receives FDA approval for Pompe disease therapy

Amicus Therapeutics has received approval from the US FDA for the two-component ...

HitGen and SGC enter drug discovery partnership

HitGen and the Structural Genomics Consortium entered a collaboration to discove...

Deka Biosciences secures $20m to advance product pipeline

Deka Biosciences has secured funding of $20m in a Series B2 financing round to a...

Regeneron’s bispecific lymphoma antibody odronextamab w...

The FDA has set 31 March 2024 as the PDUFA action date for reviewing odronextama...

Cambridge biotech Thymmune wins $37m NIH grant for thym...

The stem cell startup aims to bolster immune systems of patients born without a ...

Karuna Therapeutics files for FDA approval for schizoph...

Karuna Therapeutics has announced the submission of a NDA to the FDA for KarXT (...

ModeX wins $168m BARDA contract to develop viral antibo...

BARDA in the US has awarded a $168m Project NextGen grant to ModeX Therapeutics ...

Can reforms restore faith in India’s pharma industry af...

India is known as the 'pharmacy of the world', producing a substantial quantity ...

Leading providers of washing, disinfection and sterilis...

Pharmaceutical Technology has listed some of the leading providers of washing, d...

Republicans aren’t quite done talking about Obamacare, ...

On health care issues, the second GOP primary debate spanned drug prices, the op...

STAT+: FDA advisers vote overwhelmingly against ALS tre...

A panel of independent advisers to the FDA voted against a polarizing potential ...

STAT+: U.S. government’s next-gen Covid effort gives sm...

The U.S. government said it would give a small biotechnology firm, Gritstone bio...

Gene therapy death was caused by an unknown risk of the...

“I don’t think it was foreseeable,” a gene therapy researcher says about the dea...